Polyclonal antibody of 100 µl targeting SLC38A2/SNAT2 for FCM, ICC, IHC, WB.
| Product Specifications | |
| Application | FC, ICC, WB, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | Synthetic peptide derived from human SLC38A2 |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | 100 µl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Citations for Anti-SLC38A2 (SNAT2) (Human) pAb – 3 Found |
| Nardi, Francesca; Hoffmann, Thorsten M; Stretton, Clare; Cwiklinski, Emma; Taylor, Peter M; Hundal, Harinder S. Proteasomal modulation of cellular SNAT2 (SLC38A2) abundance and function by unsaturated fatty acid availability. The Journal Of Biological Chemistry. 2015;290(13):8173-84. PubMed - Comments: Used in: WB |
| Krokowski, Dawid; Jobava, Raul; Guan, Bo-Jhih; Farabaugh, Kenneth; Wu, Jing; Majumder, Mithu; Bianchi, Massimiliano G; Snider, Martin D; Bussolati, Ovidio; Hatzoglou, Maria. Coordinated Regulation of the Neutral Amino Acid Transporter SNAT2 and the Protein Phosphatase Subunit GADD34 Promotes Adaptation to Increased Extracellular Osmolarity. The Journal Of Biological Chemistry. 2015;290(29):17822-17837. PubMed - Comments: Used in: WB |
| Hoffmann, Thorsten M; Cwiklinski, Emma; Shah, Dinesh S; Stretton, Clare; Hyde, Russell; Taylor, Peter M; Hundal, Harinder S. Effects of Sodium and Amino Acid Substrate Availability upon the Expression and Stability of the SNAT2 (SLC38A2) Amino Acid Transporter. Frontiers In Pharmacology. 9:63. PubMed - Comments: Used in: WB |